Fund shareholders of JW Cayman Therapeutics Co Ltd
ISIN KYG5210T1040 · Cayman Islands · LEI 9845004E84F2D2AB6E81
- Fund shareholders
- 6
- Of which ETFs
- 2 4 other funds
- Value held
- 217K $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 528,500 | 108.2K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 229,000 | 46.7K $ | 0.01 % | as of Jun 30, 2026 ↗ |
| Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 110,500 | 22.6K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 105,500 | 21.6K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) China ETF SPDR INDEX SHARES FUNDS | 82,000 | 16.7K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| THE EMERGING MARKETS SMALL CAP SERIES DFA INVESTMENT TRUST CO | 5,500 | 1.1K $ | as of Jul 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 0.01 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) China ETF SPDR INDEX SHARES FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
| Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Jul 31, 2026 ↗ |
| World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Jul 31, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 6 | 0 | 1,061,000 | -1.9 % |
| 2026Q2 | 6 | -1 | 1,081,500 | -13.1 % |
| 2026Q1 | 7 | 0 | 1,244,500 | +10.3 % |
| 2025Q4 | 7 | +2 | 1,128,000 | +80.0 % |
| 2025Q3 | 5 | +2 | 626,500 | +151.1 % |
| 2025Q2 | 3 | +1 | 249,500 | +20.2 % |
| 2025Q1 | 2 | -2 | 207,500 | -70.5 % |
| 2024Q4 | 4 | -6 | 704,500 | -36.0 % |
| 2024Q3 | 10 | 0 | 1,101,350 | -5.4 % |
| 2024Q2 | 10 | -2 | 1,163,850 | -17.1 % |
| 2024Q1 | 12 | -6 | 1,404,159 | -63.8 % |
| 2023Q4 | 18 | 3,877,769 |
Cite this page
Titelia. "Fund shareholders of JW Cayman Therapeutics Co Ltd". https://titelia.com/en/stocks/jw-cayman-therapeutics-co-ltd-KYG5210T1040